KidneyIntelX check for people with diabetes and early kidney disease
Part of Hormones & metabolism, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study looks at how well a kidney test tool called KidneyIntelX works in real-world care for people with type 2 diabetes and certain stages of kidney disease. It may help doctors use the tool to better understand kidney risk and guide next steps.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have type 2 diabetes and chronic (diabetic) kidney disease in an early-to-moderate stage
- Your kidney function level and urine protein (albuminuria) fit the study’s specific ranges
- You are not in kidney failure (end-stage kidney disease) and not in kidney recovery treatment
- You have at least 6 months of prior KidneyIntelX health records before the study starts
- You are not pregnant and you are not currently in the hospital
- You are not taking Enbrel (etanercept)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new smart screening tool that helps doctors in primary care find and manage diabetic kidney disease—a common complication of diabetes. If you join, your care may be better tailored to your needs, which could help protect your kidneys.
This study is looking at different kidney health patterns in people with diabetes, especially diabetic kidney disease and people who have not developed kidney damage despite long-term diabetes. It may help researchers understand why kidney problems happen—and what protective factors might prevent them.
This study looks at simple blood tests to see if certain markers of inflammation and platelet levels are different in people with diabetic kidney disease compared to healthy people. The results might help doctors find kidney problems earlier in people with type 2 diabetes.
This study looks at how common diabetic kidney damage is in people with type 2 diabetes, and which factors can predict it. If you qualify, you may be asked to have a kidney biopsy to understand what’s happening inside your kidneys.
This trial focuses on improving how kidney damage is diagnosed and how treatment is planned for people with type 2 diabetes and kidney disease. It may help by using detailed medical history and (if done) kidney biopsy results to guide care more accurately.
This study is testing a new way to find early signs of kidney damage in people with diabetes. The goal is to catch kidney disease (diabetic nephropathy) sooner, so it can be managed more effectively.
Hear when a new Diabetic Kidney Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.